Evidence map›Paper›PMID 39470207›Full record

ArticleJournal of virology2024

Acquisition of a multibasic cleavage site does not increase MERS-CoV entry into Calu-3 human lung cells.

Markus Hoffmann, Hannah Kleine-Weber, Luise Graichen, Inga Nehlmeier, Amy Kempf, Anna-Sophie Moldenhauer, Elisabeth Braun, Abdullah M Assiri, Frank Kirchhoff, Daniel Sauter and 2 more

Abstract read
In one paragraph

Article in Journal of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Markus HoffmannInfection Biology Unit, German Primate Center- Leibniz Institute for Primate Research, Göttingen, Germany.ORCID 0000-0003-4603-7696
Hannah Kleine-WeberInfection Biology Unit, German Primate Center- Leibniz Institute for Primate Research, Göttingen, Germany.
Luise GraichenInfection Biology Unit, German Primate Center- Leibniz Institute for Primate Research, Göttingen, Germany.
Inga NehlmeierInfection Biology Unit, German Primate Center- Leibniz Institute for Primate Research, Göttingen, Germany.
Amy KempfInfection Biology Unit, German Primate Center- Leibniz Institute for Primate Research, Göttingen, Germany.
Anna-Sophie MoldenhauerInfection Biology Unit, German Primate Center- Leibniz Institute for Primate Research, Göttingen, Germany.
Elisabeth BraunInstitute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Abdullah M AssiriPreventive Health, Ministry of Health, Riyadh, Saudi Arabia.
Frank KirchhoffInstitute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.ORCID 0000-0002-7052-2360
Daniel SauterInstitute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.ORCID 0000-0001-7665-0040
Khaled R AlkharsahDepartment of Microbiology, College of Medicine, Imam Abdulrahman Bin Faisal University (IAU), Dammam, Saudi Arabia.
Stefan PöhlmannInfection Biology Unit, German Primate Center- Leibniz Institute for Primate Research, Göttingen, Germany.ORCID 0000-0001-6086-9136

Funding

Bundesministerium für Bildung und Forschung (BMBF) 01KI1723DBundesministerium für Bildung und Forschung (BMBF) FKZ 01KI20135Canon Foundation EuropeDeutsche Forschungsgemeinschaft (DFG) Heisenberg Program [SA 2676/3-1]Deutsche Forschungsgemeinschaft (DFG) PO 716/11-1Deutsche Forschungsgemeinschaft (DFG) SPP 1923 and CRC 1279EC | Horizon Europe| HORIZON EUROPE Health (Health) UNDINE [101057100]Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg (MWK) MWK K.N.K.C.014 [U21] and MWK K.N.K.C.015 [U22]Niedersächsisches Ministerium für Wissenschaft und Kultur (MWK) COFONI [14-76103-184 projects 7FF22 and 6FF22 and 10FF22]
6 · The paper itself

Abstract

Human-to-human transmission of the highly pathogenic Middle East respiratory syndrome coronavirus (MERS-CoV) is currently inefficient. However, there is concern that the virus might mutate and thereby increase its transmissibility and thus pandemic potential. The pandemic SARS-CoV-2 depends on a highly cleavable furin motif at the S1/S2 site of the viral spike (S) protein for efficient lung cell entry, transmission, and pathogenicity. Here, by employing pseudotyped particles, we investigated whether augmented cleavage at the S1/S2 site also increases MERS-CoV entry into Calu-3 human lung cells. We report that polymorphism T746K at the S1/S2 cleavage site or optimization of the furin motif increases S protein cleavage but not lung cell entry. These findings suggest that, unlike what has been reported for SARS-CoV-2, a highly cleavable S1/S2 site might not augment MERS-CoV infectivity for human lung cells.IMPORTANCEThe highly cleavable furin motif in the spike protein is required for robust lung cell entry, transmission, and pathogenicity of SARS-CoV-2. In contrast, it is unknown whether optimization of the furin motif in the spike protein of the pre-pandemic MERS-CoV increases lung cell entry and allows for robust human-human transmission. The present study indicates that this might not be the case. Thus, neither a naturally occurring polymorphism that increased MERS-CoV spike protein cleavage nor artificial optimization of the cleavage site allowed for increased spike-protein-driven entry into Calu-3 human lung cells.

Indexed as

FurinLungMiddle East Respiratory Syndrome CoronavirusSpike Glycoprotein, CoronavirusVirus InternalizationAmino Acid MotifsCell LineCoronavirus InfectionsHumansSARS-CoV-2FurinSpike Glycoprotein, CoronaviruscleavagefurinMERS-CoVproteasespike

Identifiers

PMID39470207
PMCPMC11575293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.